Tag: Alzheimer’s
AAN: Higher Fitness Level Tied to Lower Alzheimer Disease Risk
Graded association seen between levels of cardiorespiratory fitness and incident Alzheimer disease and related disorders
Few Older Adults Knowledgeable About Aducanumab for Alzheimer Disease
Less than one-quarter of older adults report they would want to take it
Mental Disorders Tied to Subsequent Dementia Onset
Associations consistent across different psychiatric conditions, for Alzheimer disease and all other dementias
Medicare May Rethink Premium Hike for Pricey Alzheimer Drug
Announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year
SAGE Detects Conversion From MCI to Dementia Early
The Self-Administered Gerocognitive Examination detects the conversion from mild cognitive impairment to dementia sooner than the MMSE
Biogen Cuts Price of Controversial Aduhelm in Half
Drug shows promise in clearing brain plaques believed to play a role in Alzheimer disease
Higher Habitual Coffee Intake May Slow Cognitive Decline
Higher baseline coffee consumption also linked to slower Aβ-amyloid accumulation during a 126-month study period as shown on brain MRI scans
Ethical Considerations Explored for Aducanumab in Alzheimer Disease
Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid
Trial Begins of Nasal Vaccine for Alzheimer Disease
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
Pricey Alzheimer Drug Drives Spike in Medicare B Premium: Officials
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms